Genomic and Functional Assays Demonstrate Reduced Gammaretroviral Vector Genotoxicity Associated With Use of the cHS4 Chromatin Insulator
Open Access
- 1 April 2009
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 17 (4), 716-724
- https://doi.org/10.1038/mt.2009.7
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activationBlood, 2008
- Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicityBlood, 2006
- The SINister side of retrovirus vectorsBlood, 2006
- Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intra- and interchromosomal interactionsNature Genetics, 2006
- Stable Gammaretroviral Vector Expression during Embryonic Stem Cell-Derived In Vitro Hematopoietic DevelopmentMolecular Therapy, 2006
- Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapyProceedings of the National Academy of Sciences, 2006
- Selection of Target Sites for Mobile DNA Integration in the Human GenomePLoS Computational Biology, 2006
- RTCGD: retroviral tagged cancer gene databaseNucleic Acids Research, 2004
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Development of virus vectors for gene therapy of β chain hemoglobinopathies: flanking with a chromatin insulator reduces γ-globin gene silencing in vivoBlood, 2002